Evidence map›Paper›PMID 35796643›Full record

ArticleCancer communications (London, England)2022

p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases.

Pilar Fajardo, Maria Taskova, Miguel A Martín-Serrano, Jonas Hansen, Sofie Slott, Anna K Jakobsen, Marie-Louise Wibom, Beñat Salegi, Alberto Muñoz, Antonio Barbachano and 6 more

Open access · goldAbstract readLetter
In one paragraph

Article in Cancer communications (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. p38γ and p38δ MAP kinases in inflammation.Biochemical Society transactions · 2026
    Review
  2. Review
  3. A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Pilar FajardoDepartment of Immunology and Oncology, National Centre of Biotechnology/Consejo Superior de Investigaciones Científicas, Darwin 3, Madrid, 28049, Spain.
Maria TaskovaDepartment of Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Miguel A Martín-SerranoDepartment of Immunology and Oncology, National Centre of Biotechnology/Consejo Superior de Investigaciones Científicas, Darwin 3, Madrid, 28049, Spain.
Jonas HansenDepartment of Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Sofie SlottDepartment of Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Anna K JakobsenDepartment of Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Marie-Louise WibomDepartment of Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Beñat SalegiDepartment of Immunology and Oncology, National Centre of Biotechnology/Consejo Superior de Investigaciones Científicas, Darwin 3, Madrid, 28049, Spain.
Alberto MuñozInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, 28029, Spain.
Antonio BarbachanoInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Madrid, 28029, Spain.
Arpita SharmaDepartment of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
John Mark GubatanDepartment of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Aida HabtezionDepartment of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Juan J Sanz-EzquerroDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología/ Consejo Superior de Investigaciones Científicas, Darwin 3, Madrid, 28049, Spain.
Kira AstakhovaDepartment of Chemistry, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.
Ana CuendaDepartment of Immunology and Oncology, National Centre of Biotechnology/Consejo Superior de Investigaciones Científicas, Darwin 3, Madrid, 28049, Spain.
Consejo Superior de Investigaciones Científicas · ESTechnical University of Denmark · DKStanford University · USStanford Medicine · USUniversity of Fribourg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsInflammatory Bowel DiseasesBiomarkersHumansMitogen-Activated Protein Kinase 13BiomarkersMitogen-Activated Protein Kinase 13

Identifiers

PMID35796643
PMCPMC9456697
OpenAlexW4284667103

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.